The Layered silicate, Montmorillonite (MMT) as a drug delivery carrier

Key Engineering Materials

Volumn 571, Issue , 2013, Pages 111-132

  Kevadiya, Bhavesh D ^a   Bajaj, Hari C ^a  

^a CSIR CENTRAL SALT AND MARINE CHEMICALS RESEARCH INSTITUTE   (India)

Author keywords

Drug carrier; Drug delivery; Hydrotalcite; Montmorillonite; Nanoclay

Indexed keywords

CLAY MINERALS; CYTOLOGY; DRUG DELIVERY; ION EXCHANGE; MEDICINE; MOLECULES; NANOCOMPOSITES; ORGANIC MINERALS; SILICATES; SWELLING; TARGETED DRUG DELIVERY;

CONTROLLED DRUG DELIVERY SYSTEMS; CONTROLLED RELEASE SYSTEMS; DRUG CARRIER; DRUG DELIVERY CARRIER; HYDROTALCITES; ION EXCHANGE PROPERTIES; LAYERED CLAY MINERALS; NANO CLAYS;

CONTROLLED DRUG DELIVERY;

EID: 84884252128     PISSN: 10139826     EISSN: 16629795     Source Type: Book Series    
DOI: 10.4028/www.scientific.net/KEM.571.111     Document Type: Article

References (79)

1. G.V. Joshi, B.D. Kevadiya, H.A. Patel, H.C. Bajaj, R.V. Jasra, Montmorillonite as a drug delivery system: Intercalation and in vitro release of timolol maleate, Int. J. Pharma. 374 (2009) 53-57.
2. 1 as drug carrier, Appl. Clay Sci. 45 (2009) 248-253.
3. G.V. Joshi, B.D. Kevadiya, H.C. Bajaj, Design and evaluation of controlled drug delivery system of buspirone using inorganic layered clay mineral, Micropor. Mesopor. Mater. 132 (2010) 526-530.
4. G.V. Joshi, B.D. Kevadiya, H.M. Mody, H.C. Bajaj, Confinement and controlled release of quinine on chitosan-montmorillonite bionanocomposites, J. Poly. Sci. Part A: Poly. Chem. 50 (2012) 423-430.
5. G.V. Joshi, R.R. Pawar, B.D. Kevadiya, H.C. Bajaj, Mesoporous synthetic hectorites: A versatile layered host with drug delivery application, Micropor. Mesopor. Mater. 142 (2011) 542-548.
6. B.D. Kevadiya, G.V. Joshi, H.C. Bajaj, Layered bionanocomposites as carrier for procainamide, Int. J. Pharma. 388 (2010) 280-286.
7. B.D. Kevadiya, G.V. Joshi, H.M. Mody, H.C. Bajaj, Biopolymer-clay hydrogel composites as drug carrier: Host-guest intercalation and in vitro release study of lidocaine hydrochloride, Appl. Clay Sci. 52 (2011) 364-367.
8. B.D. Kevadiya, T.A. Patel, D.D. Jhala, R. P. Thumbar, H. Brahmbhatt, et al, Layered inorganic nanocomposites: A promising carrier for 5-fluorouracil (5-FU), Eur. J. Pharma. Biopharma. 81 (2012) 91-101.
9. B.D. Kevadiya, R.P. Thumbar, M.M. Rajput, S. Rajkumar, et al, Montmorillonite/poly-(ε-caprolactone) composites as versatile layered material: Reservoirs for anticancer drug and controlled release property, Eur. J. Pharma. Sci. 47 (2012) 265-272.
10. K.E. Uhrich, Polymeric systems for controlled drug release, Chem. Rev. 99 (1999) 3181-3198.
11. S. Kim, J.H. Kim, O. Jeon, I.C. Kwon, K. Park, Engineered polymers for advanced drug delivery, Eur. J. Pharm. Biopharm. 71 (2009) 420-430.
12. R. Langer, Polymer-controlled drug delivery systems, Acc. Chem. Res. 26 (1993) 537-542.
13. Raghvendra, R. Saraswathi, Nano-clays and drug delivery system:an overview, IJPWR. 3 (2012) 1-16.
14. M.N. Kumar, N. Kumar, Polymeric controlled drug-delivery systems: perspective issues and opportunities, Drug Dev. Ind. Pharm. 27 (2001) 1-30.
15. J. Konta, Clay and man: Clay raw materials in the service of man, Appl. Clay Sci. 10 (1995) 275-335.
16. E.P. Giannelis, Review: Polymer layered silicate nanocomposites, Adv. Mat. 8 (1996) 29-35.
17. J.H. Choy, S.J. Choi, J.M. Oh, T. Park, Clay minerals and layered double hydroxides for novel biological applications, Appl. Clay Sci. 36 (2007) 122-132.
18. F. Forni, V. Lannuccelli, G. Coppi, M, T. Bernabei, Effect of montmorillonite on drug release from polymeric matrices, Arch. Pharm. 322 (1989) 789-793.
19. W.F. Lee, Y.T. Fu, Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels, J. Appl. Polym. Sci. 89 (2003) 3652-3660.
20. H. Komine, Simplified evaluation for swelling characteristics of bentonites, Eng. Geol. 71 (2004) 256-279.
21. A.A. Fudala, I.I. Palinko, I. Kiricsi, Preparation and characterization of hybrid organicinorganic composite materials using the amphoteric property of amino acids: amino acid intercalated layered double hydroxide and Montmorillonite, Inorg. Chem. 38 (1999) 4653-4658.
22. J.P. Zheng, L. Luan, H.Y. Wang, L.F. Xi, K.D. Yao, Study on ibuprefen/montmorillonite intercalation composites as drug release system, Appl. Clay Sci. 36 (2007) 297-301.
23. T. Kollar, I. Palinko, Z. Konya, I. Kiricsi, Intercalating amino acid guests into montmorillonite host, J. Mol. Struct. 651-653 (2003) 335-340.
24. F.H. Lin, Y.H. Lee, C.H. Jian, J.M. Wong, M.J. Shieh, C.Y. Wang, A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier, Biomaterials 23 (2002) 1981-1987.
25. Park, J.K, Choy, Y.B, Oh, J.M, Kim, J.Y, Hwang, S.J, Choy, J.H, Controlled release of donepezil intercalated in smectite clays, Int. J. Pharm. 359 (2008) 198-204.
26. Park, M, Kim, C.Y, Lee, D.H, Choi, C.L, Choi, J, Lee, S.R, Choy, J.H, Intercalation of magnesium-urea complex into swelling clay, J. Phys. Chem. Solids 65 (2004) 409-412.
27. M. Baek, J.H. Choy, S.J. Choi, Montmorillonite intercalated with glutathione for antioxidant delivery:Synthesis, characterization, and bioavailability evaluation, Int. J. Pharm. 425 (2012) 29-34.
28. Y. Dong, S.S. Feng, Poly (D, L-Lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs, Biomaterials 26 (2005) 6068-6076.
29. S.S. Feng, L. Mei, P. Anitha, C.W. Gan, W. Zhou, Poly(Lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel, Biomaterials 30 (2009) 3297-3306.
30. J.H. Chang, Y. Uk An, D. Cho, E.P. Giannelis, Poly (Lactic acid) nanocomposites: comparison of their properties with montmorillonite and synthetic mica (II), Polymer 44 (2003) 3715-3720.
31. M. Alexandre, P. Dubois, Polymer-layered silicate nanocomposites: preparation, properties and uses of a new class of materials, Mat. Sci. Eng. 28 (2000) 1-63.
32. K.S. Katti, D.R. Katti, Relationship of swelling and swelling pressure on silica water interactions in Montmorillonite, Langmuir 22 (2006) 532-7.
33. Auerbach, S. M., Carrado, K. A., Dutta, P, Handbook of Layered Materials; Eds.; Marcel Dekker: New York, Chapter 3 (2004) 91-154.
34. B. Wicklein, M. Darder, P. Aranda, E. Ruiz-Hitzky, Bio-organoclays based on phospholipids as immobilization hosts for biological species, Langmuir 26 (2010) 5217-5225.
35. D.R. Katti, P. Ghosh, S. Schmidt, K.S. Katti, Mechanical properties of the sodium montmorillonite interlayer intercalated with amino acids, Biomacromolecules 6 (2005) 3276-3282.
36. E.P. Giannelis, R. Krishnamoorti, E. Manias, Polymer-silicate nanocomposites: Model systems for confined polymers and polymer brushes, Adv. Polym. Sci. 138 (1999) 107-147.
37. J.D.F. Ramsay, S.W. Swanton, J.J. Bunce, Swelling and dispersion of smectite caly colloids: Determination of structure by neutron diffraction and small-angle neutron scattering, J. Chem. Soc. Faraday. Trans. 86 (1999) 3919-3926.
38. T. Szabo, R. Mitea, H. Leeman, G.S. Premachandra, C.T. Johnston, M. Szekeres, I. Dekany, R.A. Schoonheydt, Adsorption of protamine and papain proteins on saponite, Clays Clay Miner. 56 (2008) 494-504.
39. J.M. Oh, T.T. Biswick, J.H. Choy, Layered nanomaterials for green materials: J. Mater. Chem. 19 (2009) 2553-2563.
40. S.L. Swartzen-Allen, E. Matijevic, Surface and colloid chemistry of clays, Chem Revs. 74 (1974)74385-74400.
41. F. Tomas, et al, Layer charge and eletrophoretic mobility of smectites, Colloids Surf. 159 (1999) 351-358.
42. G.J. Chen, M.C. Yen, J.M. Wang, J. J. Lin, H.C. Chiu, Layered inorganic/enzyme nanohybrids with selectivity and structural: stability upon interacting with biomolecules, Bioconjugate. Chem. 19 (2008) 138-144.
43. A. Gurses, C{ogonek} Dogar, M. Yalci{dotless}n, M. Aci{dotless} kyi{dotless}ldiz, R. Bayrak, S. Karaca, The adsorption kinetics of the cationic dye, methylene blue, onto clay, J. Hazard. Mater. B131 (2006) 217-228.
44. A.R. Nesica, S.J. Velickovic, D.G. Antonovic, Characterization of chitosan/montmorillonite membranes as adsorbents for bezactiv orange V-3R dye, J. Hazard. Mater. 209-210 (2012) 256-263.
45. L. Wang, A. Wang, Adsorption characteristics of congo red onto the chitosan/montmorillonite nanocomposite, J. Hazard. Mater. 147 (2007) 979-985.
46. S. Kittinaovarat, P. Kansomwan, N. Jiratumnukul, Chitosan/modified montmorillonite beads and adsorption Reactive Red 120, Appl. Clay Sci. 48 (2010) 87-91.
47. P. Monvisade, P. Siriphannon, Chitosan intercalated montmorillonite: Preparation, characterization and cationic dye adsorption, Appl. Clay Sci. 42 (2009) 427-431.
48. F.H. Lin, C.H. Chen, Winston, T.K. Cheng, T.F. Kuo. Modified montmorillonite as vector for gene delivery, Biomaterials 27 (2006) 3333-3338.
49. E. Gamiz, J. Linares, R. Delgado, Assessment of two Spanish bentonites for pharmaceutical uses, Appl. Clay Sci. 6, (1992) 359-368.
50. R. Bolger, Industrial minerals in pharmaceuticals. Ind. Min. 8 (1995)52-63.
51. M.I. Carretero, Clay minerals and their beneficial effects upon human health. A review, Appl. Clay Sci. 21 (2002)155-163.
52. B. Sun, B. Ranganathan, S.S. Feng, Multifunctional poly(D, L-Lactide-coglycolide)/Montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancer, Biomaterials 29 (2008) 475-486.
53. J. Cornejo, M.C. Hermosin, J.L. White, J.R. Barnes, S.L. Hem, Role of ferric iron in the oxidation of hydrocortisone by sepiolite and palygorskite, Clays Clay Miner. 31 (1983)109-112.
54. T. Ferrand, J. Yvon, Thermal properties of clay pastes for pelotherapy, Appl. Clay Sci. 6 (1991) 21-38.
55. D. Poensin, P.H. Carpentier, C. Fechoz, S. Gasparini, Effects of mud pack treatment on skin microcirculation. Jt. Bone Spine 70 (2003) 367-370.
56. G. Sposito, N.T. Skipper, R. Sutton, S.H. Park, A.K. Soper, J.A. Greathouse, Colloquium Paper:Surface geochemistry of the clay minerals, PNAS. 96 (1999) 3358-3364.
57. C. Aguzzi, P. Cerezo, C. Viseras, C. Caramella, Use of clays as drug delivery systems: possibilities and limitations, Appl. Clay Sci. 36 (2007) 22-36.
58. M.I. Carretero, M. Pozo, Clay and non-clay minerals in the pharmaceutical industry Part I. Excipients and medical applications, Appl. Clay Sci. 46 (2009) 73-80.
59. M.I. Carretero, Clay minerals and their beneficial effects upon human health. A review, Appl. Clay Sci. 21 (2002) 155-163.
60. X. Wang, Y. Du, J. Luo, Biopolymer/montmorillonite nanocomposite: preparation, drugcontrolled release property and cytotoxicity, Nanotechnology 19 (2008) 065707 (7pp) doi:10.1088/0957-4484/19/6/065707.
61. T. Takahashi, Y. Yamada, K. Kataoka, Y. Nagasaki, Preparation of a novel PEG-clay hybrid as a DDS material: Dispersion stability and sustained release profiles J. Control. Release 107 (2005) 408.
62. D. Depan, A.P. Kumar, R.P. Singh, Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and Montmorillonite, Acta Biomater. 5 (2009) 93-100.
63. C.A. Vaiana, M.K. Leonard, L.F. Drummy, K.M. Singh, A. Bubulya, R.A. Vaia, R.R. Naik, M. P. Kadakia, Epidermal growth factor: Layered silicate nanocomposites for tissue regeneration, Biomacromolecules 12 (2011) 3139-3146.
64. S.H. Cypes, W.M. Saltzman, E.P. Giannelis, Organosilicate- polymerdrugdelivery systems: controlledrelease and enhancedmechanical properties, J, Control. Rel. 90 (2003) 163-169.
65. F.H. Lin, C.H. Chen, W.T.K. Cheng, T.F. Kuo, Modified montmorillonite as vector for gene delivery, Biomaterials 27 (2006) 3333-3338.
66. M. Kawase, Y. Hayashi, F. Kinoshita, E. Yamato, J.I. Miyazaki, J. Yamakawa, T. Ishida, M. Tamura, K. Yagi, Protective effect of montmorillonite on plasmid DNA in oral gene delivery into small intestine, Biol. Pharm. Bull. 27 (2004) 2049-2051.
67. K. Shameli, M.B. Ahmad, W.M.Z.W. Yunus, A. Rustaiyan, N.A. Ibrahim, M. Zargar, Y. Abdollahi, Green synthesis of silver/montmorillonite/chitosan bionanocomposites using the UV irradiation method and evaluation of antibacterial activity, Int.J. Nanomed. 5 (2010) 875-887.
68. W.F. Lee, Y.T. Fu, Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels. J. Appl. Polym. Sci. 89 (2003) 3652-3660.
69. J.E. Browne, J.R. Feldkamp, J.L. White, S.L. Hem, Characterisation and adsorptive properties of pharmaceutical grade clays. J. Pharm. Sci. 69 (1980) 816-823.
70. G. Lagaly, Pesticide-clay interactions and formulations. Appl. Clay Sci. 18 (2001) 205-209.
71. J. Tolls, Sorption of veterinary pharmaceuticals in soils: A review, Environ. Sci. Technol. 35 (2001) 3397-3406.
72. H.A Patel, R.S Somani, H.C Bajaj, R.V Jasra, Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment, Bull. Mater. Sci. 29 (2006) 133-145.
73. St edition (2006), Elsevier publication, Amsterdam.
74. K. Yano, A. Usuki, A. Okada, Synthesis and properties of polyimide-clay hybrid films, J. Polym. Sci. A-Polym. Chem. 35 (2000) 2289-2294.
75. S.H. Cypes, W.M. Saltzman, E. P. Giannelis, Organosilicate-polymer drug delivery systems: controlled release and enhanced mechanical properties: J. Control. Release 90 (2003) 163-169.
76. G.V. Joshi, B D. Kevadiya, H.C. Bajaj, Controlled release formulation of ranitidinecontaining montmorillonite and Eudragit® E-100 Montmorillonite as drug delivery carrier, Drug Dev. Ind. Pharm. 36 (2010) 1046-1053.
77. J.J. Lin, J.C. Wei, T.Y. Juang, W.C. Tsai, Preparation of protein-silicate hybrids from polyamine intercalation of layered montmorillonite, Langmuir 23 (2007) 1995-1999.
78. T.S. Anirudhan, S. Sandeep, Synthesis, characterization, cellular uptake and cytotoxicity of a multifunctional magnetic nanocomposite for the targeted delivery and controlled release of doxorubicin to cancer cells, J. Mater. Chem, 22 (2012) 12888-12899.
79. S.L. Madurai, S.W. Joseph, A.B. Mandal, J. Tsibouklis, B.S.R. Reddy, Intestine-specific, oral delivery of captopril/Montmorillonite: Formulation and release kinetics, Nanoscale. Res. Lett. 6 (2011) 1-8.